{{Rsnum
|rsid=2296336
|Gene=ITPR3
|Chromosome=6
|position=33668883
|Orientation=minus
|GMAF=0.2943
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=ITPR3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 10.8 | 46.2 | 43.1
| HCB | 24.4 | 53.3 | 22.2
| JPT | 13.6 | 59.1 | 27.3
| YRI | 1.7 | 35.6 | 62.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 24.4 | 53.3 | 22.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

[[rs2296336]] has been reported in a Swedish study to be associated with [[type-1 diabetes]].

The risk allele (oriented to the dbSNP entry) is (G); the odds ratio associated with heterozygotes is 1.3 (CI 1.00-1.69), and for homozygotes, 2.9 (CI 1.88-4.59). {{PMID|16960798|OA=1
}}

{{PMID|18340361}} suggests this SNP does not play a direct role in [[type-1 diabetes]], and was only seen in the previous study due to being in linkage disequilibrium with specific alleles of the HLA DQB1 gene.

{{PMID Auto
|PMID=19143813
|Title=Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}